abstract |
The invention relates to 4,5,6,7-tetrahydro-1H-pyrazolo [4,3-c] substituted pyridines of formula I, their use as medicaments, and pharmaceutical preparations comprising them. (see Formula) Compounds of formula I act on the TASK-1 potassium channel. The compounds are suitable for the treatment or prevention of atrial arrhythmias, for example atrial fibrillation (AF) or atrial flutter. |